SCHEMBL29531520

SCHEMBL29531520

O=C1NCc2c(O)cc(F)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 8/20 0.53
▸ PIK3CB P42338 8/20 0.53
▸ PIK3CA P42336 7/20 0.53
▸ GRM2 Q14416 1/20 0.47
▸ MET P08581 1/20 0.43
▸ PIK3CG P48736 6/20 0.41
▸ PARP1 P09874 2/20 0.40
▸ PARP10 Q53GL7 1/20 0.40
▸ GRM5 P41594 2/20 0.38
▸ KDR P35968 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ CSNK1A1 P48729 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ DYRK1B Q9Y463 1/20 0.38
▸ FABP6 P51161 1/20 0.37
▸ ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18863211 0.84 GRM2 (0.50) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL3532428 0.79 GRM2 (0.46) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL31159005 0.79 GRM2 (0.46) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL29662767 0.73 PIK3CD (0.46) PIK3CDPIK3CBPIK3CAPIK3CGKDR
SCHEMBL21349280 0.73 GRM2 (0.41) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL17141660 0.69 CLK4 (0.46) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL8169835 0.69 GRM2 (0.44) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL12240961 0.69 CLK4 (0.44) PIK3CDPIK3CBPIK3CAGRM2MET
SCHEMBL27085852 0.69 GRM2 (0.44) PIK3CDPIK3CBPIK3CAGRM2PIK3CG
SCHEMBL6297545 0.68 PARP1 (0.70) PIK3CDPIK3CBPIK3CAPARP1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2025-11-04 — — US disclosed
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2022-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof CUL4B, CUL4A, UBQLN1 PIK3CD 1078/4885PIK3CB 889/4885PIK3CA 2520/4885
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF CUL4B, CUL4A, UBQLN1 PIK3CD 1078/4885PIK3CB 889/4885PIK3CA 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback